HEPATOLOGÍA EXPERIMENTAL Y VECTORIZACIÓN DE FÁRMACOS
HEVEFARM
King's College London
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de King's College London (9)
2021
-
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: A systematic review and individual participant data meta-analysis
Obstetrical and Gynecological Survey
-
Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis
The Lancet Gastroenterology and Hepatology, Vol. 6, Núm. 7, pp. 547-558
2019
-
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses
Obstetrical and Gynecological Survey
-
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses
The Lancet, Vol. 393, Núm. 10174, pp. 899-909
2017
-
Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid
PLoS ONE, Vol. 12, Núm. 4
-
Suitability of small diagnostic peripheral-blood samples for cell-therapy studies
Cytotherapy, Vol. 19, Núm. 2, pp. 311-326
2016
-
Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum
Hepatology, Vol. 63, Núm. 4, pp. 1287-1298
2014
-
Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4
Hepatology, Vol. 59, Núm. 5, pp. 1921-1931
2013
-
Maternal cholestasis during pregnancy programs metabolic disease in offspring
Journal of Clinical Investigation, Vol. 123, Núm. 7, pp. 3172-3181